World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
63251
World Ranking
7496
National Ranking
289

Overview

Harry Bartelink is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research primarily focuses on medical fields such as medicine and biochemistry, genetics, and molecular biology, with specific work in cancer research, oncology, pathology and forensic medicine, otorhinolaryngology, and radiation.

The scientist's areas of study include breast cancer treatment studies, breast lesions and carcinomas, head and neck cancer studies, advanced radiotherapy techniques, global cancer incidence and screening, medical imaging techniques and applications, and lung cancer treatments and mutations.

Recent significant publications include:

  • Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial, 2020, The Lancet Oncology
  • Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial, 2020, International Journal of Radiation Oncology*Biology*Physics
  • Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925, 2021, JNCI Journal of the National Cancer Institute
  • The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial, 2022, Radiotherapy and Oncology
  • Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation, 2020, Frontiers in Oncology

Harry Bartelink has collaborated frequently with several coauthors, including:

  • Philip Poortmans
  • Femke van der Leij
  • Alain Fourquet
  • H. Struikmans
  • Caroline Weltens

Their publications are regularly found in a variety of scientific venues. Most frequently, works appear in:

  • Radiotherapy and Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • European Journal of Cancer
  • The Lancet Oncology
  • JNCI Journal of the National Cancer Institute

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

    H Bartelink;F Roelofsen;F Eschwege;P Rougier

  • Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial

    Joop A. van Dongen;Adri C. Voogd;Ian S. Fentiman;Catherine Legrand

  • Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

    Harry Bartelink;Jean-Claude Horiot;Philip M. Poortmans;Henk Struikmans

  • Regional Nodal Irradiation in Early-Stage Breast Cancer

    Timothy J. Whelan;Ivo A. Olivotto;Wendy R. Parulekar;Ida Ackerman

  • Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

    Howard Y. Chang;Dimitry S. A. Nuyten;Julie B. Sneddon;Trevor Hastie

  • Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

    Harry Bartelink;Jean-Claude Horiot;Philip Poortmans;Henk Struikmans

  • Internal mammary and medial supraclavicular irradiation in breast cancer

    P.M.P. Poortmans;S. Collette;C. Kirkove;E. van Limbergen

  • Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

    Maartje J. Hooning;Akke Botma;Berthe M. P. Aleman;Margreet H. A. Baaijens

  • Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

    Berthe M.P. Aleman;Alexandra W. van den Belt-Dusebout;Willem J. Klokman;Mars B. van’t Veer

  • Late effects toxicity scoring: the SOMA scale

    J J Pavy;J Denekamp;J Letschert;B Littbrand

  • Late cardiotoxicity after treatment for Hodgkin lymphoma

    Berthe M. P. Aleman;Alexandra W. van den Belt-Dusebout;Marie L. De Bruin;Mars B. van 't Veer

  • Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

    Bas Kreike;Marieke van Kouwenhove;Hugo M Horlings;Britta Weigelt

  • Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

    Adri C. Voogd;Maja Nielsen;Johannes L. Peterse;Mogens Blichert-Toft

  • Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

    Jean-Pierre Julien;Nina Bijker;Ian S Fentiman;Johannes L Peterse

  • Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

    Saskia Litière;Gustavo Werutsky;Ian S Fentiman;Emiel Rutgers

  • Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

    Harry Bartelink;Philippe Maingon;Philip Poortmans;Caroline Weltens

  • Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.

    van Dongen Ja;Bartelink H;Fentiman Is;Lerut T

  • Prognostic factors of neck node metastasis.

    G. B. Snow;A. A. Annyas;E. A. Van Slooten;H. Bartelink

Frequent Co-Authors

Alain Fourquet
Alain Fourquet Institute Curie
Philip Poortmans
Philip Poortmans University of Antwerp
Laurence Collette
Laurence Collette European Organisation for Research and Treatment of Cancer
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Marc J. van de Vijver
Marc J. van de Vijver University of Amsterdam
Johannes L. Peterse
Johannes L. Peterse Antoni van Leeuwenhoek Hospital
Simon Horenblas
Simon Horenblas Antoni van Leeuwenhoek Hospital
Joos V. Lebesque
Joos V. Lebesque Antoni van Leeuwenhoek Hospital
Lori J. Pierce
Lori J. Pierce University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Medicine in the USA, there are several alternative and complementary educational pathways available online. These options not only offer flexibility but can also help you enter the healthcare workforce faster or advance your career in specialized fields.

If you're seeking a quick entry into nursing, online lpn programs provide a streamlined route to becoming a Licensed Practical Nurse. For those already holding advanced nursing credentials, the fastest post master's pmhnp tracks can lead to a specialized career as a Psychiatric-Mental Health Nurse Practitioner, focusing on mental health services.

Those interested in healthcare management and leadership might consider an affordable healthcare administration degree online. This pathway is ideal for students looking to oversee operations within hospitals, clinics, or other healthcare organizations. For even greater cost savings, explore the cheapest master's in healthcare administration to gain advanced management skills without accumulating substantial debt.

Each of these online degrees offers unique career opportunities and can serve as standalone options or stepping stones into further medical or healthcare studies.

Best Scientists Citing Harry Bartelink

Trending Scientists